Trial Details
COMPLETEDBasic Information
| Clinical ID | c2394 |
|---|---|
| Identifier | NCT03557788 |
| Trial Title | Changes in Microbiota and Metabolomic Profile Between Rifaximin Responders and Non-responders In Diarrhoea-Predominant Irritable Bowel Syndrome |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome With Diarrhea |
| Interventions | DRUG: Rifaximin Oral Tablet |
Participant Information
| Sponsor | National University Hospital, Singapore |
|---|---|
| City | Singapore |
| Country/Region | Singapore |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2018-05-07 |
|---|---|
| Primary Completion Date | 2021-08-13 |
| Completion Date | 2021-08-13 |